CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
penicillin and metronidazole in peritonsillar abscessdrug
Likely dose
penicillin and metronidazole in peritonsillar abscess 000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01255670
NCT01255670N/ACompleted
CompareCT.gov

Penicillin and Metronidazole in Treatment of Peritonsillar Abscess - Prospective, Double-blind, Randomized, Placebo-controlled Study

Helsinki University Central Hospital·interventional·Posted Dec 7, 2010·Updated May 11, 2021

In Brief

A clinical study evaluating penicillin and metronidazole in peritonsillar abscess for Peritonsillar Abscess. Completed, enrolled 200 participants across 1 site.

Detailed Summary

Treatment of peritonsillar abscess varies. To study whether broad spectrum antibiotics are required in addition to abscess drainage, a prospective, double blind, placebo-controlled, randomized study on 200 adult patients with peritonsillar abscess is performed. 100 patients are given penicillin and metronidazole and 100 patients get penicillin and placebo. Recovery and recurrence are analyzed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeritonsillar Abscess
CountriesFinland
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 7, 2010
Enrollment StartFeb 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.6 years ago

Interventions

penicillin and metronidazole in peritonsillar abscessdrug

Peroral Penicillin: 1000 000 IU 3 times a day for 10 days Peroral metronidazole: 500 mg 3 times a day for 7 days